Abstract

BackgroundBeside the cirrhotic one, non-cirrhotic hyperammonemia (HA) can also cause neuro-degeneration and establishment of 'Hyperammonemic Encephalopathy', ultimately leading to the coma stage. We have done pilot study on aqueous extract of Andrographis paniculata herb against HA induced oxidative stress in rats. Andrographolide (AGP) is the major component isolated from of A paniculata and reported to have various biological activities. PurposePresent study aimed to explore the therapeutic potentiality of AGP on rat model of non cirrhotic acute HA. MethodsRotarod and traction test was performed to access the motor function. Brain and serum ammonia level were assayed to confirm occurrence of HA. Malondialdehyde (MDA), reduced glutathione (GSH), protein carbonylation levels and activity of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione reductase (GR) were studied as oxidative stress markers. Expression of two NMDAR subunits, NR2A, 2B, nNOS and level of nitrite (NO2), cGMP in cerebral cortex and cerebellum were assayed to study the NMDAR-nNOS-cGMP cascade. ResultAcute HA caused motor dysfunction in rats. MDA level and protein carbonylation, increased significantly while SOD, catalase, GPx and GR got suppressed and NMDAR-nNOS-cGMP cascade activated in cerebral cortex and cerebellum. All these suggested establishment of hyperammonemic encephalopathy. AGP treatment restored the motor function, lowered the ammonia level, suppressed the oxidative stress markers, NR2A, 2B, nNOS over-expression and elevated NO2, cGMP levels in cortex and cerebellum. ConclusionOur study showed AGP could be a potential natural anti-hyperammonemic drug as it has prevented the development of acute hyperammonemic encaphalopathy in rats by suppressing NMDAR-nNOS-cGMP cascade and oxidative stress in cerebral cortex and cerebellum.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.